本文轉載自原廠電子報:Reaction Biology | www.reactionbiology.com | 電子報原文
Screen a Panel of Tumor Models to Fast Track your IO Drug Discovery Project
|
|
|
Screening new test substances on a panel of syngenic tumor models is useful for fast and economic efficacy testing of immune-modulating drugs, either as a single treatment or in combination with immune-checkpoint inhibitors.
|
|
|
|
Order deadline: February 24th
Study start: March 4th
Results due: April 30th
|
|
|
|
|